文章摘要
基于倾向性评分匹配法的血浆D-二聚体升高与新型冠状病毒肺炎重症化相关性研究
Correlation between increasing plasma D-dimer level and acute exacerbation of coronavirus disease 2019 based on propensity score matching method
  
DOI:10.3969/j.issn.1007-8134.2021.03.004
中文关键词: 新型冠状病毒肺炎  D-二聚体  重症化  倾向性评分匹配
英文关键词: coronavirus disease 2019  D-dimer  acute exacerbation  propensity score matching
基金项目:
作者单位
徐 静 阜阳市第二人民医院肝病科 
李莎莎 阜阳市第二人民医院肝病科 
李风成 阜阳市第二人民医院肝病科 
高学武 阜阳市第二人民医院肝病科 
王金玲 阜阳市第二人民医院肝病科 
姜 宁 阜阳市第二人民医院肝病科 
谭 林 阜阳市第二人民医院肝病科 
摘要点击次数: 364
全文下载次数: 386
中文摘要:
      目的 评估血浆D-二聚体(D-dimer, D-D)与新型冠状病毒肺炎(coronavirus disease 2019, COVID-19)重症化的相关性。方法 回顾性分析2020年1月20日—2月8日在阜阳市第二人民医院住院的102例COVID-19患者的临床资料,将患者按血浆D-D是否升高分为D-D不升高组与D-D持续升高组,比较2组患者的临床资料,并进行倾向性评分匹配及生存分析,评价D-D水平对于COVID-19重症化的作用。结果 最终纳入102例COVID-19确诊患者,中位年龄42.2(31.7,49.6)岁,60例(58.8%)为男性,19例(18.6%)存在基础疾病,6例(5.9%)有吸烟史,7例(6.9%)有间断饮酒史,74例(72.5%)有流行病学史。与D-D不升高组(n=85)相比,D-D持续升高组(n=17)患者的年龄更高,其中年龄>50岁的患者占58.8%,淋巴细胞绝对值更低,LDH水平更高(P均<0.05)。D-D持续升高组有8例患者出现了重症化(47.1%),D-D不升高组有7例(8.2%)出现重症化(P<0.05)。基于多因素Logistic回归进行匹配,匹配成功后D-D升高组有8例(47.1%)患者出现了重症化,D-D不升高组有4例(11.8%)出现重症化(P<0.05),CoX风险比例回归分析结果显示D-D持续升高是疾病进展的独立风险因素,其HR为4.372(95% CI: 1.313~14.556)。结论 血浆D-D的持续升高是COVID-19重症化的高危因素。
英文摘要:
      Objective To evaluate the correlation between plasma D-dimer (D-D) level and acute exacerbation of coronavirus disease 2019 (COVID-19). Methods A retrospective analysis was performed for the clinical data of 102 COVID-19 patients who were admitted to the No. 2 People’s Hospital of Fuyang City from January 20, 2020 to February 8, 2020. The patients were divided into 2 groups according to the absence or presence of the increasing plasma D-D: non-increasing D-D group and continuously increasing D-D group. The clinical data of patients in 2 groups were compared. Propensity score matching and survival analysis were carried out to evaluate the impact of plasma D-D level on the acute exacerbation of COVID-19. Results Finally, 102 confirmed patients were included. Their median age was 42.2 (31.7, 49.6) years, including 60 (58.8%) male cases, 19 (18.6%) cases had underlying diseases, 6 (5.9%) cases had smoking history, 7 (6.9%) cases had intermittent drinking history, and 74 cases (72.5%) had epidemiological history. In the continuously increasing D-D group (n=17), the age of patients was higher and patients aged>50 years accounted for 58.8%, the absolute lymphocyte count was lower. The LDH level was higher than that in non-increasing D-D group (n=85) (P<0.05). Eight patients (47.1%) in the continuously increasing D-D group and 7 patients (8.2%) in the non-increasing D-D group developed acute exacerbation (P<0.05). The propensity score matching was performed based on multivariate Logistic regression. After successful matching, 8 patients (47.1%) in the continuously increasing D-D group and 4 patients (11.8%) in the non-increasing D-D group developed acute exacerbation (P<0.05). CoX risk proportional regression analysis showed that continuously increasing D-D was an independent risk factor for disease progression, with its hazard ratio (HR) of 4.372 (95% CI: 1.313-14.556). Conclusions The continuously increasing plasma D-D is a high-risk factor for acute exacerbation of COVID-19.
HTML   查看全文   下载PDF阅读器
关闭